CONMED tried to wrestle supply chain issues into submission for Q1. Made progress, but, as CEO Beyer said, “We have more work ...

FDA clears a novel approach to treating osteopenia and osteoporosis. This is the latest venture led by serial Silicon Valley ...

NuVasive loses patent fight over certain pedicle screws and bone anchors. The winning plaintiff is Roger P. Jackson M.D.

Is orthopedics ready for implantable brain chips and telepathic large joint movement? FDA cleared Neuralink’s first implant ...

Rich Mueller, formerly with AcroMed, Theken and NuVasive, is Life Spine’s new President and CEO. Great news for the future of ...

Your Critical Vote coming up. Get informed. Make an objective decision. SUPPORT your Academy and Society. Here is your GUIDE ...

Albert DaCosta’s heartfelt note to colleagues and friends the day after his sale to Zimmer closed…was beautiful. We reprint ...

Gentamycin loaded UHMPWE? Impossible you say? Mass General’s “Eureka” moment, now a paper in JBJS, showed its possible, with ...

An incalculable loss: famed neurosurgeon Dr. Michael Groff and his family perished in an awful plane crash. Here is more ...

Centinel Spine and its new “Match the Disc” program, fueled a whopping 33% sales growth rate for Q1, 2025. To put that in ...

Two investigational drugs are progressing through the regulatory pipeline with notable promise, aiming to address two of the most persistent and impactful comorbidities in orthopedic medicine: smoking ...

The U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) study for a novel bone graft substitute. What makes this novel, is that this bone graft substitute ...